PYROGEN TESTING MARKET ANALYSIS

Pyrogen Testing Market, By Test Type (Limulus Amoebocyte Lysate (LAL) Test, TAL Test, Monocyte Activation Test (MAT), Rabbit Pyrogen Test (RPT), and Recombinant Factor C Assay (rFC)), By Product Type (Instruments, Kits, and Reagents), By End User (Pharmaceutical and Biotech Companies, Food and Beverages Companies, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Nov 2020
Code : CMI243
Pages :170
Formats :
Excel and PDF
Industry : Clinical Diagnostic

Market Challenges And Opportunities

Pyrogen Testing Market: Restraints

Stringent government regulations, which control the manufacture, distribution, marketing, and sales of medical devices and drugs is expected to hinder growth of the global pyrogen testing market during the forecast period.

Stringent regulations, which control the manufacture, distribution, marketing, and sales of medical devices and drugs

Increasing research & development of therapeutic drugs and medical devices is expected to drive the market growth over the forecast period

Increasing research and development of therapeutic drugs and medical devices is propelling growth of the pyrogen testing market over the forecast period. According to the United Nations Educational, Scientific and Cultural Organization (UNESCO), November 2016, an estimated US$ 1.7 trillion was spent on research and development for various medical applications, globally. Moreover, the U.S. Food and Drug Administration (FDA) and its Center for Drug Evaluation and Research (CDER) approved around 59 novel drugs in 2018 compared to 46 approvals of new molecule entities in 2017.